分子感染症検査の世界市場：市場規模・シェア・動向、業界分析 (製品/サービス別・種類別・検査の種類別・疾患別・技術別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)

Polaris Market Research社の最新調査によると、分子感染症検査の市場規模は2034年までに347億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

分子感染症検査とは、病原体の遺伝物質を検出・分析し、正確かつ早期の疾患特定を可能にする高度な診断技術を指します。分子感染症検査市場の主な動向は、1回の検査で複数の病原体を同時に検出できるマルチプレックス分子診断法の採用が増加していることです。この進歩により、診断効率が向上し、納期が短縮され、臨床上の意思決定が改善されます。特に急性期医療現場における迅速かつ広範な診断ソリューションに対する需要の高まりは、多重アッセイのルーチン分子検査への統合をさらに促進し、感染症管理における役割を強化しています。

分子感染症検査市場の需要を形成するもう一つの大きな動向は、診断ワークフローにおける自動化と人工知能（AI）の統合の高まりです。自動化された分子検査プラットフォームは、検査室の効率を改善し、人的ミスを最小限に抑え、検査需要の増加に対応するための拡張性を向上させています。AI主導のデータ解析は結果の解釈をさらに洗練させ、より正確な診断と予測分析を促進しています。自動化とAIの組み合わせにより分子診断が合理化され、さまざまな医療環境において検査がより利用しやすく信頼できるものとなり、分子感染症検査市場の成長が加速しています。

分子感染症検査市場：分析概要

疾患別では、性感染症（STD）分野が2024年の分子感染症検査市場シェアをリードしており、これはSTI罹患率の上昇と精密かつ早期診断ソリューションへのニーズの高まりが背景にあります。

製品・サービス別では、試薬・キット分野が予測期間中に最も急速な市場成長を遂げると予測され、これはさまざまな医療環境での分子診断検査の利用増加によるものです。

北米は2024年の分子感染症検査市場の売上高シェアで首位に浮上したが、これは医療インフラが整備されていること、高度な診断技術の採用率が高いこと、分子検査を支援する規制の枠組みがしっかりしていることに起因しています。

アジア太平洋の分子感染症検査市場は、医療投資の拡大、疾病の早期発見に対する意識の高まり、感染症の有病率の上昇を背景に、予測期間中に最も高い成長率を示すと予想されます。

世界の主な市場参入企業には、アボット社、ダナハー社、バイオメリュー社、ホフマン・ラ・ロシュ社、バイオ・ラッド・ラボラトリーズ社、アジレント・テクノロジー社、ベクトン・ディッキンソン社、ホロジック社（ジェン・プローブ社）、イルミナ社、グリフォルス社、キアゲン社、シーメンス・ヘルスイニアース社、シスメックス社、ブルカー社、サーモフィッシャーサイエンティフィック社などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の分子感染症検査市場の洞察

• 市場スナップショット
• 分子感染症検査の市場力学
  • 促進要因と機会
    • 感染症の増加
    • 分子診断における急速な技術進歩
  • 抑制要因と課題
    • 一貫性のない払い戻しポリシー
• PESTLE分析
• 分子感染症検査市場：流通チャネルの動向
• バリューチェーン分析

第5章 世界の分子感染症検査市場：製品・サービス別

• 主な分析結果
• イントロダクション
• 試薬・キット
• 装置
• サービス・ソフトウェア

第6章 世界の分子感染症検査市場：種類別

• 主な分析結果
• イントロダクション
• マルチプレックス検査
• シングルプレックス検査

第7章 世界の分子感染症検査市場：検査の種類別

• 主な分析結果
• イントロダクション
• 臨床検査
• PoC（ポイントオブケア）検査

第8章 世界の分子感染症検査市場：疾患別

• 主な分析結果
• イントロダクション
• 呼吸器感染症
• 消化器感染症
• 性感染症
• 院内感染
• 膣炎
• 髄膜炎
• 媒介性疾患
• その他の感染症

第9章 世界の分子感染症検査市場：技術別

• 主な分析結果
• イントロダクション
• ポリメラーゼ連鎖反応（PCR）
• 等温核酸増幅技術（INACT）
• DNAシーケンシング・次世代シーケンシング
• in situ ハイブリダイゼーション
• DNAマイクロアレイ
• その他

第10章 世界の分子感染症検査市場：エンドユーザー別

• 主な分析結果
• イントロダクション
• 診断検査室
• 病院・診療所
• その他

第11章 世界の分子感染症検査市場：地域別

• 主な分析結果
• イントロダクション
  • 分子感染症検査市場の分析：地域別 (2020～2034年)
• 北米
  • 北米：製品・サービス別（2020～2034年）
  • 北米：種類別（2020～2034年）
  • 北米：検査の種類別（2020～2034年）
  • 北米：疾患別（2020～2034年）
  • 北米：技術別（2020～2034年）
  • 北米：エンドユーザー別（2020～2034年）
  • 米国
  • カナダ
• 欧州
  • 欧州：製品・サービス別（2020～2034年）
  • 欧州：種類別（2020～2034年）
  • 欧州：検査の種類別（2020～2034年）
  • 欧州：疾患別（2020～2034年）
  • 欧州：技術別（2020～2034年）
  • 欧州：エンドユーザー別（2020～2034年）
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：製品・サービス別、2020年～2034年
  • アジア太平洋：種類別（2020～2034年）
  • アジア太平洋：検査の種類別（2020～2034年）
  • アジア太平洋：疾患別（2020～2034年）
  • アジア太平洋：技術別（2020～2034年）
  • アジア太平洋：エンドユーザー別（2020～2034年）
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：製品・サービス別（2020～2034年）
  • 中東・アフリカ：種類別（2020～2034年）
  • 中東およびアフリカ：検査の種類別（2020～2034年）
  • 中東・アフリカ：疾患別（2020～2034年）
  • 中東・アフリカ：技術別（2020～2034年）
  • 中東・アフリカ：エンドユーザー別（2020～2034年）
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品・サービス別（2020～2034年）
  • ラテンアメリカ：種類別（2020～2034年）
  • ラテンアメリカ：検査の種類別（2020～2034年）
  • ラテンアメリカ：疾患別（2020～2034年）
  • ラテンアメリカ：技術別（2020～2034年）
  • ラテンアメリカ：エンドユーザー別（2020～2034年）
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第12章 競合情勢

• 事業拡大・企業買収の分析
  • 事業拡大
  • 企業買収
• 提携/協業/合意/公開

第13章 企業プロファイル

• Abbott
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Grifols S.A.
• Hologic, Inc. (Gen-Probe)
• Illumina, Inc.
• Qiagen
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific

List of Tables:

• Table 1 Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 2 Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 3 Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 4 UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 5 UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 6 UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 7 UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 8 UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 9 UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 10 France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 11 France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 12 France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 13 France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 14 France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 15 France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 16 Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 17 Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 18 Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 19 Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 20 Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 21 Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 22 Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 23 Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 24 Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 25 Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 26 Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 27 Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 28 Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 29 Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 30 Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 31 Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 32 Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 33 Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 34 Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 35 Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 36 Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 37 Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 38 Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 39 Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 40 Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 41 Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 42 Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 43 Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 44 Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 45 Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 46 Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 47 Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 48 Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 52 Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 57 Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 58 China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 59 China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 60 China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 61 China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 62 China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 63 China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 64 India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 65 India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 66 India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 67 India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 68 India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 69 India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 70 Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 71 Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 72 Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 73 Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 74 Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 75 Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 76 Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 77 Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 78 Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 79 Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 80 Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 81 Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 82 Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 83 Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 84 Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 85 Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 86 Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 87 Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 88 South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 89 South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 90 South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 91 South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 92 South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 93 South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 94 Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 95 Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 96 Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 97 Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 98 Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 99 Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 100 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 101 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 102 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 103 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 104 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 105 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 106 Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 107 Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 108 Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 109 Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 110 Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 111 Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 112 Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 113 Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 114 Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 115 Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 116 Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 117 Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 118 UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 119 UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 120 UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 121 UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 122 UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 123 UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 124 Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 125 Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 126 Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 127 Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 128 Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 129 Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 130 South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 131 South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 132 South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 133 South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 134 South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 135 South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 136 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 137 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 138 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 139 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 140 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 141 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 142 Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 143 Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 144 Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 145 Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 146 Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 147 Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 148 Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 149 Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 150 Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 151 Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 152 Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 153 Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 154 Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 155 Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 156 Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 157 Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 158 Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 159 Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 160 Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 161 Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 162 Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 163 Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 164 Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 165 Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• Table 166 Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• Table 167 Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• Table 168 Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• Table 169 Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• Table 170 Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• Table 171 Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Molecular Infectious Disease Testing Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product & Service
• Figure 7. Global Molecular Infectious Disease Testing Market, by Product & Service, 2024 & 2034 (USD Billion)
• Figure 8. Market by Type
• Figure 9. Global Molecular Infectious Disease Testing Market, by Type, 2024 & 2034 (USD Billion)
• Figure 10. Market by Test Type
• Figure 11. Global Molecular Infectious Disease Testing Market, by Test Type, 2024 & 2034 (USD Billion)
• Figure 12. Market by Disease
• Figure 13. Global Molecular Infectious Disease Testing Market, by Disease, 2024 & 2034 (USD Billion)
• Figure 14. Market by Technology
• Figure 15. Global Molecular Infectious Disease Testing Market, by Technology, 2024 & 2034 (USD Billion)
• Figure 16. Market by End User
• Figure 17. Global Molecular Infectious Disease Testing Market, by End User, 2024 & 2034 (USD Billion)

The molecular infectious disease testing market size is expected to reach USD 34.73 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Infectious Disease Testing Market Share, Size, Trends, Industry Analysis Report: By Product & Service, Type (Multiplex Testing and Singleplex Testing), Test Type, Disease, Technology, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular infectious disease testing refers to advanced diagnostic techniques that detect and analyze the genetic material of pathogens to enable precise and early disease identification. A major molecular infectious disease testing market trend is the increasing adoption of multiplex molecular diagnostics, which allow the simultaneous detection of multiple pathogens in a single test. This advancement improves diagnostic efficiency, reduces turnaround time, and improves clinical decision-making. The growing demand for rapid and wide diagnostic solutions, particularly in acute care settings, is further driving the integration of multiplex assays into routine molecular testing, strengthening their role in infectious disease management.

Another major trend shaping the molecular infectious disease testing market demand is the rising integration of automation and artificial intelligence (AI) in diagnostic workflows. Automated molecular testing platforms are improving laboratory efficiency, minimizing human errors, and improving scalability to meet the increasing testing demand. AI-driven data analysis is further refining result interpretation, facilitating more accurate diagnoses and predictive analytics. The combination of automation and AI is streamlining molecular diagnostics, making testing more accessible and reliable across various healthcare settings, thereby accelerating molecular infectious disease testing market growth.

Molecular Infectious Disease Testing Market Report Highlights

In terms of disease, the sexually transmitted disease (STD) segment led the molecular infectious disease testing market share in 2024, driven by the rising incidence of STIs and the growing need for precise and early diagnostic solutions.

Based on product & service, the reagents & kits segment is anticipated to experience the most rapid growth in the market during the forecast period, fueled by the increasing utilization of molecular diagnostic tests across various healthcare settings.

North America emerged as the leading region in the global molecular infectious disease testing market revenue share in 2024, attributed to its well-developed healthcare infrastructure, high adoption of advanced diagnostic technologies, and a robust regulatory framework supporting molecular testing.

The molecular infectious disease testing market in Asia Pacific is expected to witness the highest growth rate during the forecast period, driven by expanding healthcare investments, greater awareness of early disease detection, and a rising prevalence of infectious diseases.

A few global key market players include Abbott; Danaher Corporation; bioMerieux SA; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; Hologic, Inc. (Gen-Probe); Illumina, Inc., Grifols S.A.; Qiagen; Siemens Healthineers AG; Sysmex Corporation; Bruker Corporation; and Thermo Fisher Scientific.

Polaris Market Research has segmented the molecular infectious disease testing market report on the basis of product & service, type, test type, disease, technology, end user, and region:

By Product & Service Outlook (Revenue, USD Billion, 2020-2034)

• Reagents & Kits
• Instruments
• Services & Software

By Type Outlook (Revenue, USD Billion, 2020-2034)

• Multiplex Testing
• Singleplex Testing

By Test Type Outlook (Revenue, USD Billion, 2020-2034)

• Laboratory Tests
• Point-of-Care Tests

By Disease Outlook (Revenue, USD Billion, 2020-2034)

• Respiratory Infectious Diseases
• Gastrointestinal Infectious Diseases
• Sexually Transmitted Diseases
• Hospital-Acquired Infections
• Vaginitis
• Meningitis
• Vector-Borne Diseases
• Other Infectious Diseases

By Technology Outlook (Revenue, USD Billion, 2020-2034)

• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA-Sequencing & Next-Generation Sequencing
• In-Situ Hybridization
• DNA Microarrays
• Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Vietnam
• Australia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Molecular Infectious Disease Testing Market Insights

• 4.1. Molecular Infectious Disease Testing Market - Distribution Channel Snapshot
• 4.2. Molecular Infectious Disease Testing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Cases of Infectious Diseases
    • 4.2.1.2. Rapid Technological Advancements in Molecular Diagnostics
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Inconsistent Reimbursement Policies
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Molecular Infectious Disease Testing Market Distribution Channel Trends
• 4.6. Value Chain Analysis

5. Global Molecular Infectious Disease Testing Market, by Product & Service

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
• 5.3. Reagents & Kits
  • 5.3.1. Global Molecular Infectious Disease Testing Market, by Pan-based Molecular Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
• 5.4. Instruments
  • 5.4.1. Global Molecular Infectious Disease Testing Market, by Instruments, by Region, 2020-2034 (USD Billion)
• 5.5. Services & Software
  • 5.5.1. Global Molecular Infectious Disease Testing Market, by Services & Software, by Region, 2020-2034 (USD Billion)

6. Global Molecular Infectious Disease Testing Market, by Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
• 6.3. Multiplex Testing
  • 6.3.1. Global Molecular Infectious Disease Testing Market, by Multiplex Testing, by Region, 2020-2034 (USD Billion)
• 6.4. Singleplex Testing
  • 6.4.1. Global Molecular Infectious Disease Testing Market, by Singleplex Testing, by Region, 2020-2034 (USD Billion)

7. Global Molecular Infectious Disease Testing Market, by Test Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
• 7.3. Laboratory Tests
  • 7.3.1. Global Molecular Infectious Disease Testing Market, by Laboratory Tests, by Region, 2020-2034 (USD Billion)
• 7.4. Point-of-Care Tests
  • 7.4.1. Global Molecular Infectious Disease Testing Market, by Point-of-Care Tests, by Region, 2020-2034 (USD Billion)

8. Global Molecular Infectious Disease Testing Market, by Disease

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
• 8.3. Respiratory Infectious Diseases
  • 8.3.1. Global Molecular Infectious Disease Testing Market, by Respiratory Infectious Diseases, by Region, 2020-2034 (USD Billion)
• 8.4. Gastrointestinal Infectious Diseases
  • 8.4.1. Global Molecular Infectious Disease Testing Market, by Gastrointestinal Infectious Diseases, by Region, 2020-2034 (USD Billion)
• 8.5. Sexually Transmitted Diseases
  • 8.5.1. Global Molecular Infectious Disease Testing Market, by Sexually Transmitted Diseases, by Region, 2020-2034 (USD Billion)
• 8.6. Hospital-Acquired Infections
  • 8.6.1. Global Molecular Infectious Disease Testing Market, by Hospital-Acquired Infections, by Region, 2020-2034 (USD Billion)
• 8.7. Vaginitis
  • 8.7.1. Global Molecular Infectious Disease Testing Market, by Vaginitis Diseases, by Region, 2020-2034 (USD Billion)
• 8.8. Meningitis
  • 8.8.1. Global Molecular Infectious Disease Testing Market, by Meningitis, by Region, 2020-2034 (USD Billion)
• 8.9. Vector-Borne Diseases
  • 8.9.1. Global Molecular Infectious Disease Testing Market, by Vector-Borne Diseases, by Region, 2020-2034 (USD Billion)
• 8.10. Other Infectious Diseases
  • 8.10.1. Global Molecular Infectious Disease Testing Market, by Other Infectious Diseases, by Region, 2020-2034 (USD Billion)

9. Global Molecular Infectious Disease Testing Market, by Technology

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
• 9.3. Polymerase Chain Reaction
  • 9.3.1. Global Molecular Infectious Disease Testing Market, by Polymerase Chain Reaction, by Region, 2020-2034 (USD Billion)
• 9.4. Isothermal Nucleic Acid Amplification Technology
  • 9.4.1. Global Molecular Infectious Disease Testing Market, by Isothermal Nucleic Acid Amplification Technology, by Region, 2020-2034 (USD Billion)
• 9.5. DNA-Sequencing & Next-Generation Sequencing
  • 9.5.1. Global Molecular Infectious Disease Testing Market, by DNA-Sequencing & Next-Generation Sequencing, by Region, 2020-2034 (USD Billion)
• 9.6. In-Situ Hybridization
  • 9.6.1. Global Molecular Infectious Disease Testing Market, by In-Situ Hybridization, by Region, 2020-2034 (USD Billion)
• 9.7. DNA Microarrays
  • 9.7.1. Global Molecular Infectious Disease Testing Market, by DNA Microarrays, by Region, 2020-2034 (USD Billion)
• 9.8. Others
  • 9.8.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Molecular Infectious Disease Testing Market, by End User

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Global Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• 10.3. Diagnostic Laboratories
  • 10.3.1. Global Molecular Infectious Disease Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
• 10.4. Hospitals & Clinics
  • 10.4.1. Global Molecular Infectious Disease Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
• 10.5. Others
  • 10.5.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)

11. Global Molecular Infectious Disease Testing Market, by Geography

• 11.1. Key Findings
• 11.2. Introduction
  • 11.2.1. Molecular Infectious Disease Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
• 11.3. Molecular Infectious Disease Testing Market - North America
  • 11.3.1. North America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 11.3.2. North America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 11.3.3. North America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 11.3.4. North America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 11.3.5. North America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 11.3.6. North America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.3.7. Molecular Infectious Disease Testing Market - US
    • 11.3.7.1. US: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.3.7.2. US: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.3.7.3. US: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.3.7.4. US: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.3.7.5. US: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.3.7.6. US: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.3.8. Molecular Infectious Disease Testing Market - Canada
    • 11.3.8.1. Canada: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.3.8.2. Canada: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.3.8.3. Canada: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.3.8.4. Canada: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.3.8.5. Canada: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.3.8.6. Canada: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• 11.4. Molecular Infectious Disease Testing Market - Europe
  • 11.4.1. Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 11.4.2. Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 11.4.3. Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 11.4.4. Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 11.4.5. Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 11.4.6. Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.7. Molecular Infectious Disease Testing Market - UK
    • 11.4.7.1. UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.7.2. UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.7.3. UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.7.4. UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.7.5. UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.7.6. UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.8. Molecular Infectious Disease Testing Market - France
    • 11.4.8.1. France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.8.2. France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.8.3. France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.8.4. France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.8.5. France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.8.6. France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.9. Molecular Infectious Disease Testing Market - Germany
    • 11.4.9.1. Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.9.2. Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.9.3. Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.9.4. Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.9.5. Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.9.6. Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.10. Molecular Infectious Disease Testing Market - Italy
    • 11.4.10.1. Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.10.2. Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.10.3. Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.10.4. Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.10.5. Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.10.6. Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.11. Molecular Infectious Disease Testing Market - Spain
    • 11.4.11.1. Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.11.2. Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.11.3. Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.11.4. Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.11.5. Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.11.6. Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.12. Molecular Infectious Disease Testing Market - Netherlands
    • 11.4.12.1. Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.12.2. Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.12.3. Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.12.4. Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.12.5. Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.12.6. Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.13. Molecular Infectious Disease Testing Market - Russia
    • 11.4.13.1. Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.13.2. Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.13.3. Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.13.4. Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.13.5. Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.13.6. Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4.14. Molecular Infectious Disease Testing Market - Rest of Europe
    • 11.4.14.1. Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.14.2. Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.14.3. Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.14.4. Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.14.5. Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.14.6. Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• 11.5. Molecular Infectious Disease Testing Market - Asia Pacific
  • 11.5.1. Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 11.5.2. Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 11.5.3. Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 11.5.4. Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 11.5.5. Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 11.5.6. Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.7. Molecular Infectious Disease Testing Market - China
    • 11.5.7.1. China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.7.2. China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.7.3. China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.7.4. China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.7.5. China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.7.6. China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.8. Molecular Infectious Disease Testing Market - India
    • 11.5.8.1. India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.8.2. India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.8.3. India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.8.4. India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.8.5. India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.8.6. India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.9. Molecular Infectious Disease Testing Market - Malaysia
    • 11.5.9.1. Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.9.2. Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.9.3. Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.9.4. Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.9.5. Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.9.6. Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.10. Molecular Infectious Disease Testing Market - Japan
    • 11.5.10.1. Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.10.2. Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.10.3. Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.10.4. Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.10.5. Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.10.6. Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.11. Molecular Infectious Disease Testing Market - Indonesia
    • 11.5.11.1. Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.11.2. Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.11.3. Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.11.4. Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.11.5. Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.11.6. Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.12. Molecular Infectious Disease Testing Market - South Korea
    • 11.5.12.1. South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.12.2. South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.12.3. South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.12.4. South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.12.5. South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.12.6. South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.13. Molecular Infectious Disease Testing Market - Australia
    • 11.5.13.1. Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.13.2. Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.13.3. Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.13.4. Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.13.5. Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.13.6. Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5.14. Molecular Infectious Disease Testing Market - Rest of Asia Pacific
    • 11.5.14.1. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.14.2. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.14.3. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.14.4. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.14.5. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.14.6. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• 11.6. Molecular Infectious Disease Testing Market - Middle East & Africa
  • 11.6.1. Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 11.6.2. Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 11.6.3. Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 11.6.4. Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 11.6.5. Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 11.6.6. Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6.7. Molecular Infectious Disease Testing Market - Saudi Arabia
    • 11.6.7.1. Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.7.2. Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.7.3. Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.7.4. Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.7.5. Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.7.6. Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6.8. Molecular Infectious Disease Testing Market - UAE
    • 11.6.8.1. UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.8.2. UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.8.3. UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.8.4. UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.8.5. UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.8.6. UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6.9. Molecular Infectious Disease Testing Market - Israel
    • 11.6.9.1. Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.9.2. Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.9.3. Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.9.4. Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.9.5. Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.9.6. Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6.10. Molecular Infectious Disease Testing Market - South Africa
    • 11.6.10.1. South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.10.2. South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.10.3. South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.10.4. South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.10.5. South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.10.6. South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6.11. Molecular Infectious Disease Testing Market - Rest of Middle East & Africa
    • 11.6.11.1. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.11.2. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.11.3. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.11.4. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.11.5. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.11.6. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
• 11.7. Molecular Infectious Disease Testing Market - Latin America
  • 11.7.1. Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 11.7.2. Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 11.7.3. Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 11.7.4. Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 11.7.5. Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 11.7.6. Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.7.7. Molecular Infectious Disease Testing Market - Mexico
    • 11.7.7.1. Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.7.7.2. Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.7.7.3. Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.7.7.4. Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.7.7.5. Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.7.7.6. Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.7.8. Molecular Infectious Disease Testing Market - Brazil
    • 11.7.8.1. Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.7.8.2. Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.7.8.3. Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.7.8.4. Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.7.8.5. Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.7.8.6. Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.7.9. Molecular Infectious Disease Testing Market - Argentina
    • 11.7.9.1. Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.7.9.2. Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.7.9.3. Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.7.9.4. Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.7.9.5. Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.7.9.6. Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.7.10. Molecular Infectious Disease Testing Market - Rest of Latin America
    • 11.7.10.1. Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.7.10.2. Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.7.10.3. Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.7.10.4. Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.7.10.5. Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.7.10.6. Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)

12. Competitive Landscape

• 12.1. Expansion and Acquisition Analysis
  • 12.1.1. Expansion
  • 12.1.2. Acquisitions
• 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

• 13.1. Abbott
  • 13.1.1. Company Overview
  • 13.1.2. Financial Performance
  • 13.1.3. Product Benchmarking
  • 13.1.4. Recent Development
• 13.2. Agilent Technologies, Inc.
  • 13.2.1. Company Overview
  • 13.2.2. Financial Performance
  • 13.2.3. Product Benchmarking
  • 13.2.4. Recent Development
• 13.3. Becton, Dickinson and Company
  • 13.3.1. Company Overview
  • 13.3.2. Financial Performance
  • 13.3.3. Product Benchmarking
  • 13.3.4. Recent Development
• 13.4. bioMérieux SA
  • 13.4.1. Company Overview
  • 13.4.2. Financial Performance
  • 13.4.3. Product Benchmarking
  • 13.4.4. Recent Development
• 13.5. Bio-Rad Laboratories, Inc.
  • 13.5.1. Company Overview
  • 13.5.2. Financial Performance
  • 13.5.3. Product Benchmarking
  • 13.5.4. Recent Development
• 13.6. Bruker Corporation
  • 13.6.1. Company Overview
  • 13.6.2. Financial Performance
  • 13.6.3. Product Benchmarking
  • 13.6.4. Recent Development
• 13.7. Danaher Corporation
  • 13.7.1. Company Overview
  • 13.7.2. Financial Performance
  • 13.7.3. Product Benchmarking
  • 13.7.4. Recent Development
• 13.8. F. Hoffmann-La Roche Ltd
  • 13.8.1. Company Overview
  • 13.8.2. Financial Performance
  • 13.8.3. Product Benchmarking
  • 13.8.4. Recent Development
• 13.9. Grifols S.A.
  • 13.9.1. Company Overview
  • 13.9.2. Financial Performance
  • 13.9.3. Product Benchmarking
  • 13.9.4. Recent Development
• 13.10. Hologic, Inc. (Gen-Probe)
  • 13.10.1. Company Overview
  • 13.10.2. Financial Performance
  • 13.10.3. Product Benchmarking
  • 13.10.4. Recent Development
• 13.11. Illumina, Inc.
  • 13.11.1. Company Overview
  • 13.11.2. Financial Performance
  • 13.11.3. Product Benchmarking
  • 13.11.4. Recent Development
• 13.12. Qiagen
  • 13.12.1. Company Overview
  • 13.12.2. Financial Performance
  • 13.12.3. Product Benchmarking
  • 13.12.4. Recent Development
• 13.13. Siemens Healthineers AG
  • 13.13.1. Company Overview
  • 13.13.2. Financial Performance
  • 13.13.3. Product Benchmarking
  • 13.13.4. Recent Development
• 13.14. Sysmex Corporation
  • 13.14.1. Company Overview
  • 13.14.2. Financial Performance
  • 13.14.3. Product Benchmarking
  • 13.14.4. Recent Development
• 13.15. Thermo Fisher Scientific
  • 13.15.1. Company Overview
  • 13.15.2. Financial Performance
  • 13.15.3. Product Benchmarking
  • 13.15.4. Recent Development